Replies to post #92992 on Biotech Values

[DewDiligence]

I would still think [FDA] would have had to sign off the mfg plant and the consistency of the process.

True, the FDA did do this; however, completing this task did not require the FDA to be privy to the algorithm that underlies the generation of the peptide variants.